CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.

Scan to Download iOS&Android APP

Handel Eli Lilly & Co - LLY CFD

337.93
2.28%
2.49
Lav: 329.73
Høj: 341.12
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Opsummering
  • Historisk Data
  • Begivenheder
  • Resultatopgørelse
  • Saldo
  • Cash flow
  • Ejerskab
Handelsbetingelser
Spænd 2.49
Long position, gebyr natten over

Long position overnight fee


Margin. Your investment $1,000.00
Gebyr for natten over -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Gå til platform
-0.030779%
Short position, gebyr natten over

Short position overnight fee


Margin. Your investment $1,000.00
Gebyr for natten over -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Gå til platform
-0.013666%
Gebyr natten over, tid 22:00 (UTC)
Min. handlet mængde 1
Valuta USD
Margen 20%
Aktiebørs United States of America
Kommission på handel 0%

*Information provided by Capital.com

Eli Lilly and Co ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

Nøglestatistikker
Tidligere luk* 330.39
Åben* 329.73
1-Års Ændring* 31.38%
Dagens Spænd* 329.73 - 341.12
52-Ugers Spænd 231.87-384.44
Gennemsnitlig Volumen (10 dage) 3.98M
Gennemsnitlig Volumen (3 måneder) 59.59M
Market Cap 322.19B
P/E-forhold 49.13
Udestående aktier 950.18M
Omsætning 28.54B
EPS 6.90
Dividend (Udbytte %) 1.33302
Beta 0.33
Næste indtjeningsopgørelse Apr 27, 2023

Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Luk Change Change (%) Åben High Low
Feb 3, 2023 337.93 5.58 1.68% 332.35 342.09 328.30
Feb 2, 2023 330.39 -2.41 -0.72% 332.80 334.80 316.14
Feb 1, 2023 342.15 1.23 0.36% 340.92 345.40 336.80
Jan 31, 2023 343.91 5.17 1.53% 338.74 344.11 338.74
Jan 30, 2023 340.18 -1.86 -0.54% 342.04 347.28 339.15
Jan 27, 2023 341.77 -2.99 -0.87% 344.76 347.70 341.32
Jan 26, 2023 347.65 -2.14 -0.61% 349.79 351.79 346.30
Jan 25, 2023 349.26 7.35 2.15% 341.91 349.50 341.91
Jan 24, 2023 345.92 -16.82 -4.64% 362.74 364.89 339.80
Jan 23, 2023 341.82 -2.04 -0.59% 343.86 345.86 339.80
Jan 20, 2023 345.80 1.01 0.29% 344.79 348.73 341.12
Jan 19, 2023 350.82 1.39 0.40% 349.43 355.30 349.43
Jan 18, 2023 351.45 -4.05 -1.14% 355.50 358.73 351.25
Jan 17, 2023 357.38 -1.09 -0.30% 358.47 361.50 356.17
Jan 13, 2023 361.23 6.08 1.71% 355.15 362.95 355.15
Jan 12, 2023 358.72 3.25 0.91% 355.47 360.15 351.69
Jan 11, 2023 359.86 7.67 2.18% 352.19 361.49 348.71
Jan 10, 2023 352.54 5.75 1.66% 346.79 352.96 342.22
Jan 9, 2023 349.45 -13.34 -3.68% 362.79 364.60 348.43
Jan 6, 2023 362.71 4.92 1.38% 357.79 366.20 356.41

Eli Lilly & Co Events

Time (UTC) Country Event
No events scheduled
View all events
  • Årlig
  • Pr kvartal
2016 2017 2018 2019 2020 2021
Total omsætning 21222.1 19973.8 21493.3 22319.5 24539.8 28318.4
Omsætning 21222.1 19973.8 21493.3 22319.5 24539.8 28318.4
Kost af omsætning, Total 5654.9 4447.7 4681.7 4721.2 5483.3 7312.8
Bruttofortjeneste 15567.2 15526.1 16811.6 17598.3 19056.5 21005.6
Totale Driftsudgifter 17763.3 17970.5 17958.8 17287.9 18481.8 22366.5
Salgs/Generelle/Admin. Udgifter, Total 6452 5982.4 5975.1 6213.8 6121.2 6431.6
Forskning & Udvikling 5243.9 5096.2 5051.2 5595 6085.7 7025.9
Usædvanlig Udgift (Indkomst) 412.5 2444.2 2250.8 757.9 791.6 1596.2
Driftsindtægter 3458.8 2003.3 3534.5 5031.6 6058 5951.9
Renteindkomst (Udgift), Netto Ikke-Drift -76.5 -58.6 -83.2 -320.2 -326.6 -137.5
Andre, Netto -8.3 360.1 228.8 554.5 1498.5 341.1
Netto Indkomst Før Skat 3374 2304.8 3680.1 5265.9 7229.9 6155.5
Netto Indkomst Efter Skat 2737.6 4493.6 3325.9 4637.9 6193.7 5581.7
Netto Indkomst Før Ekstra Ting 2737.6 4493.6 3325.9 4637.9 6193.7 5581.7
Netto Indkomst 2737.6 -204.1 3232 8318.4 6193.7 5581.7
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting 2737.6 4493.6 3325.9 4637.9 6193.7 5581.7
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting 2737.6 -204.1 3232 8318.4 6193.7 5581.7
Fortyndet Netto Indkomst 2737.6 -204.1 3232 8318.4 6193.7 5581.7
Fortyndet Vægtet Gennemsnit Aktier 1061.82 1052.02 1033.67 935.684 912.505 911.681
Fortyndet EPS Uden Ekstraordinære Ting 2.5782 4.27139 3.21757 4.95669 6.78758 6.12243
Dividends per Share - Common Stock Primary Issue 2.04 2.08 2.25 2.58 2.96 3.4
Fortyndet Normaliseret EPS 2.89874 6.15171 5.37021 5.70063 7.63447 7.79951
Totale Ekstraordinære Ting -4697.7 -93.9 3680.5 0 0
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total omsætning 6805.6 6740.1 6772.8 7999.9 7810
Omsætning 6805.6 6740.1 6772.8 7999.9 7810
Kost af omsætning, Total 1878.6 1953.2 1430.8 2050.2 2072.1
Bruttofortjeneste 4927 4786.9 5342 5949.7 5737.9
Totale Driftsudgifter 5650.3 5336.7 5296.8 6082.7 5405.7
Salgs/Generelle/Admin. Udgifter, Total 1576 1685.7 1577.9 1592 1557.9
Forskning & Udvikling 1684.8 1672.8 1708.9 1959.4 1610.1
Usædvanlig Udgift (Indkomst) 510.9 25 579.2 481.1 165.6
Driftsindtægter 1155.3 1403.4 1476 1917.2 2404.3
Renteindkomst (Udgift), Netto Ikke-Drift 219.2 133.9 -323.4 -167.2 -503.3
Andre, Netto 101.9 56.6 92.7 89.9 152.6
Netto Indkomst Før Skat 1476.4 1593.9 1245.3 1839.9 2053.6
Netto Indkomst Efter Skat 1355.3 1390.2 1110.1 1726.1 1902.9
Netto Indkomst Før Ekstra Ting 1355.3 1390.2 1110.1 1726.1 1902.9
Netto Indkomst 1355.3 1390.2 1110.1 1726.1 1902.9
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting 1355.3 1390.2 1110.1 1726.1 1902.9
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting 1355.3 1390.2 1110.1 1726.1 1902.9
Fortyndet Netto Indkomst 1355.3 1390.2 1110.1 1726.1 1902.9
Fortyndet Vægtet Gennemsnit Aktier 912.4 910.4 910.8 911.624 906.4
Fortyndet EPS Uden Ekstraordinære Ting 1.48542 1.52702 1.21882 1.89343 2.0994
Dividends per Share - Common Stock Primary Issue 0.85 0.85 0.85 0.85 0.98
Fortyndet Normaliseret EPS 2.02635 1.55448 1.80644 2.41408 2.28211
Totale Ekstraordinære Ting 0
  • Årlig
  • Pr kvartal
2016 2017 2018 2019 2020 2021
Totale Nuværende Aktiver 15101.4 19202.1 20549.6 13709.6 17462.1 18452.4
Likvider og Kortsigtede Investeringer 6038.6 8034.1 7408.9 2438.5 3681.3 3908.6
Likvider & Lignende 4582.1 6536.2 7320.7 2337.5 3657.1 3818.5
Kortsigtede Investeringer 1456.5 1497.9 88.2 101 24.2 90.1
Totale Tilgodehavender, Netto 4766.3 5262.2 5776.8 5541.5 6929 8127.2
Accounts Receivable - Trade, Net 4029.4 4546.3 5776.8 4547.3 5875.3 6672.8
Total Inventory 3561.9 4458.3 3098.1 3190.7 3980.3 3886
Prepaid Expenses 734.6 1447.5 2036.7 2538.9 2871.5 2530.6
Total Assets 38805.9 44981 43908.4 39286.1 46633.1 48806
Property/Plant/Equipment, Total - Net 8252.6 8826.5 7996.1 8405 8681.9 8985.1
Property/Plant/Equipment, Total - Gross 16777.6 18091.1 16663 17566.6 18252.6 18961.8
Accumulated Depreciation, Total -8525 -9264.6 -8666.9 -9161.6 -9570.7 -9976.7
Goodwill, Net 3972.7 4370.1 1366.6 3679.4 3766.5 3892
Intangibles, Net 4357.9 4029.2 1068 6618 7450 7691.9
Long Term Investments 5207.5 5678.8 2005.4 1962.4 2966.8 3212.6
Other Long Term Assets, Total 1913.8 2874.3 10922.7 4911.7 6305.8 6572
Total Current Liabilities 10986.6 14535.9 11888.1 11775.2 12481.6 15052.7
Accounts Payable 1349.3 1410.7 1207.1 1405.3 1606.7 1670.6
Accrued Expenses 896.9 997.9 955.6 915.5 997.2 958.1
Notes Payable/Short Term Debt 1299.3 2696.8 498.9 1494.2 0 0
Current Port. of LT Debt/Capital Leases 638.1 1009.8 603.3 5.1 8.7 1538.3
Other Current Liabilities, Total 6803 8420.7 8623.2 7955.1 9869 10885.7
Total Liabilities 24798.2 33388.8 34079.7 36679.2 40991.5 39826.8
Total Long Term Debt 8367.8 9940.5 9196.4 13817.9 16586.6 15346.4
Long Term Debt 8358.8 9931.8 9196.4 13817.9 16586.6 15346.4
Capital Lease Obligations 9 8.7
Minority Interest 72.8 75.7 1080.4 92.2 183.6 175.6
Other Liabilities, Total 5371 8836.7 10602.1 8806.4 9639.8 7518.4
Total Equity 14007.7 11592.2 9828.7 2606.9 5641.6 8979.2
Common Stock 688.5 687.9 661 598.8 598.2 596.3
Additional Paid-In Capital 5640.6 5817.8 6583.6 6685.3 6778.5 6833.4
Retained Earnings (Accumulated Deficit) 16046.3 13894.1 11395.9 4920.4 7830.2 8958.5
Treasury Stock - Common -80.5 -75.8 -69.4 -60.8 -55.7 -52.7
Unrealized Gain (Loss) 224 113.5 4.9 14.8 3.7
Other Equity, Total -8511.2 -8845.3 -8742.4 -9541.7 -9524.4 -7360
Total Liabilities & Shareholders’ Equity 38805.9 44981 43908.4 39286.1 46633.1 48806
Total Common Shares Outstanding 1100.88 1100.01 1057.64 957.526 956.59 953.653
Other Current Assets, Total 2229.1 0
Deferred Income Tax 1312.7 2187.5 2099.9 1733.7
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Totale Nuværende Aktiver 16604.5 17295.5 17808.3 18452.4 16964.7
Likvider og Kortsigtede Investeringer 3051.4 3271.2 3825.3 3908.6 2568.3
Likvider & Lignende 3002.4 3220 3788.2 3818.5 2459.2
Kortsigtede Investeringer 49 51.2 37.1 90.1 109.1
Totale Tilgodehavender, Netto 6658.6 6902.8 7025 8127.2 7805.7
Accounts Receivable - Trade, Net 5592.8 5829.4 5914.3 6672.8 6322.5
Total Inventory 3660.8 3824.9 3907.4 3886 3893
Prepaid Expenses 3233.7 3296.6 3050.6 2530.6 2697.7
Total Assets 46838.3 47809 48187 48806 46919.3
Property/Plant/Equipment, Total - Net 8630.1 8855.5 8920.4 8985.1 9102.7
Property/Plant/Equipment, Total - Gross 18273.5 18697.7 18883.2 18961.8 19241
Accumulated Depreciation, Total -9643.4 -9842.2 -9962.8 -9976.7 -10138.3
Goodwill, Net 3877.4 3884.2 3884.1 3892 3892
Intangibles, Net 8087.8 7985.4 7887.7 7691.9 7482.4
Long Term Investments 3232.4 3474.9 3350.5 3212.6 2727.3
Other Long Term Assets, Total 6406.1 6313.5 6336 6572 6750.2
Total Current Liabilities 11714.2 15093.2 13682 15052.7 13386
Accounts Payable 1639.6 1597.8 1566.8 1670.6 1433.3
Accrued Expenses 649.9 755.5 836.6 958.1 693.1
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 4.9 1778.5 1563 1538.3 1355.9
Other Current Liabilities, Total 9419.8 10961.4 9715.6 10885.7 9903.7
Total Liabilities 39939.6 41364.6 40430 39826.8 37588.5
Total Long Term Debt 16199.6 14736.6 15522.4 15346.4 15152.9
Long Term Debt 16199.6 14736.6 15522.4 15346.4 15152.9
Deferred Income Tax 2200.6 1857.3 1632.5 1733.7 1286.1
Minority Interest 200.6 219.1 197.1 175.6 131.2
Other Liabilities, Total 9624.6 9458.4 9396 7518.4 7632.3
Total Equity 6898.7 6444.4 7757 8979.2 9330.8
Common Stock 599.7 598.1 598.2 596.3 594.1
Additional Paid-In Capital 6579.2 6669.2 6758 6833.4 6656.3
Retained Earnings (Accumulated Deficit) 9181.3 8530.1 9639.4 8958.5 9369.4
Treasury Stock - Common -52.7 -52.7 -52.7 -52.7 -50.5
Unrealized Gain (Loss) 4.5 9.1 6.8 3.7 -18.1
Other Equity, Total -9413.3 -9309.4 -9192.7 -7360 -7220.4
Total Liabilities & Shareholders’ Equity 46838.3 47809 48187 48806 46919.3
Total Common Shares Outstanding 959.019 956.575 956.589 953.653 950.155
  • Årlig
  • Pr kvartal
2016 2017 2018 2019 2020 2021
Netto indkomst/Startlinje 2737.6 -204.1 3232 8318.4 6193.7 5581.7
Likvider Fra Driftsaktiviteter 4851 5615.6 5524.5 4836.6 6499.6 7260.7
Likvider Fra Driftsaktiviteter 1496.6 1567.3 1609 1232.6 1323.9 1547.6
Deferred Taxes 439.5 -787.9 326.8 62.4 -134.5 -802.3
Ikke-Likvide Ting 661.4 1835.4 2735.4 -3089.6 -136.1 1956.3
Cash Taxes Paid 700.6 246.5 1101.5 1180.5 954.6 1598.8
Likvid Rente Betalt 146.4 192.7 223.8 305.5 345.8 338
Ændringer i Driftskapital -484.1 3204.9 -2378.7 -1687.2 -747.4 -1022.6
Likvider fra Investeringsaktiviteter -3139.1 -3783.6 1906 -8082.9 -2258.9 -2762.3
Kapitaludgifter -1092 -2163.6 -3018.2 -1353.5 -2029.1 -1873.2
Andre Investerings-Cash-Flow-Ting, Total -2047.1 -1620 4924.2 -6729.4 -229.8 -889.1
Likvider fra Financieringsaktiviteter -559.8 142.6 -5904.9 -2324.5 -3137.1 -4131.3
Financiering af Cash-Flow-Ting -300.8 -364.4 -372.8 -200.1 -241.6 -295.9
Total Cash Dividends Paid -2158.5 -2192.1 -2311.8 -2409.8 -2687.1 -3086.8
Udstedelse (Pensionering) af Aktier, Netto -600.1 -299.8 -2491 -4400 -500 -1250
Udstedelse (Pensionering) af Gæld, Netto 2499.6 2998.9 -729.3 4685.4 291.6 501.4
Udenlandsk Børs Effekter -236.4 -20.5 -63.6 -89.9 216 -205.7
Netto Ændring i Likviditet 915.7 1954.1 1462 -5660.7 1319.6 161.4
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 1355.3 2745.5 3855.6 5581.7 1902.9
Cash From Operating Activities 1697.4 3472.9 5104.2 7260.7 2499.2
Cash From Operating Activities 350.3 719.6 1101.9 1547.6 435.7
Deferred Taxes -119.1 -413.8 -709.8 -802.3 -506.6
Non-Cash Items 213.7 303.2 1404.6 1956.3 712.7
Changes in Working Capital -102.8 118.4 -548.1 -1022.6 -45.5
Cash From Investing Activities -1283.5 -1766.8 -2383.3 -2762.3 -1013.8
Capital Expenditures -492.1 -1023.4 -1479 -1873.2 -857.2
Other Investing Cash Flow Items, Total -791.4 -743.4 -904.3 -889.1 -156.6
Cash From Financing Activities -1058.4 -2141.6 -2604.8 -4131.3 -2878.3
Financing Cash Flow Items -279.9 -294.8 -295.3 -295.9 -282.4
Total Cash Dividends Paid -774.8 -1543.1 -2313.5 -3086.8 -885.5
Issuance (Retirement) of Stock, Net 0 -500 -500 -1250 -1500
Issuance (Retirement) of Debt, Net -3.7 196.3 504 501.4 -210.4
Foreign Exchange Effects -10.2 -1.6 15 -205.7 33.6
Net Change in Cash -654.7 -437.1 131.1 161.4 -1359.3
Investornavn Investortype Procent udestående Aktiebeholdning Aktieændring Beholdningsdato IOmsætningsscore
Lilly Endowment, Inc. Investment Advisor 10.8347 102948810 -210000 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 7.6008 72221213 994066 2022-09-30 LOW
PNC Wealth Management Investment Advisor 5.4451 51738161 -44061 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.2364 40253792 58949 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.5343 33582472 168444 2022-09-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 3.3604 31929656 631015 2022-09-30 LOW
Capital World Investors Investment Advisor 3.0547 29024874 282228 2022-09-30 LOW
PRIMECAP Management Company Investment Advisor 2.9486 28017155 -421333 2022-09-30 LOW
T. Rowe Price Associates, Inc. Investment Advisor 2.5054 23805927 3379269 2022-09-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 2.2989 21843288 -1593968 2022-09-30 LOW
State Farm Insurance Companies Insurance Company 1.8324 17410725 0 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.6935 16091249 373938 2022-09-30 LOW
Jennison Associates LLC Investment Advisor/Hedge Fund 1.0592 10064742 -293324 2022-09-30 LOW
JP Morgan Asset Management Investment Advisor 0.866 8228610 173535 2022-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.8435 8014500 -246196 2021-12-31 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7439 7068030 -132558 2022-09-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.6244 5933104 -307204 2022-09-30 LOW
Capital International Investors Investment Advisor 0.5893 5599174 637189 2022-09-30 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.5885 5591703 -216451 2022-09-30 LOW
BofA Global Research (US) Research Firm 0.5868 5576096 -144521 2022-09-30 LOW

Hvorfor vælge Capital.com? Vores tal taler for sig selv.

Capital.com Group
+485000+

Handlende

65000+

Månedlkige, aktive klienter

$48000000+

Månedlig investeringsvolumen

$28000000+

Hævet hver måned

Handelslommeregner

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Handelskurtage
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Gearing
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben

Luk

Short Long

Eli Lilly Company profile

Om Eli Lilly & Co

Eli Lilly and Company er en virksomhed, der fremstiller lægemidler. Virksomheden beskæftiger sig med opdagelse, udvikling, fremstilling, markedsføring og salg af farmaceutiske produkter i hele verden. Virksomhedens diabetesprodukter omfatter Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta og Trulicity. Virksomhedens onkologiske produkter omfatter Alimta, Cyramza, Erbitux, Retevmo, Tyvyt og Verzenio. Virksomhedens immunologiske produkter består af Olumiant og Taltz. Virksomhedens neurovidenskabelige produkter omfatter Cymbalta, Emgality, Reyvow og Zyprexa. Selskabets andre terapier består af Bamlanivimab, etesevimab, Cialis og Forteo. Selskabet fremstiller og distribuerer sine produkter gennem anlæg i USA, herunder Puerto Rico, og omkring otte andre lande. Virksomhedens produkter sælges i ca. 120 lande. Dets datterselskaber omfatter bl.a. Acanthas Pharma, Inc, Alnara Pharmaceuticals, Inc, ARMO Biosciences, Inc og Avid Radiopharmaceuticals, Inc.

Industry: Pharmaceuticals (NEC)

Lilly Corporate Ctr
Drop Code 1094
INDIANAPOLIS
INDIANA 46285-0001
US

Resultatopgørelse

  • Annual
  • Quarterly

Folk ser også

Oil - Crude

73.41 Price
-3.570% 1D Chg, %
Long position, gebyr natten over -0.0223%
Short position, gebyr natten over 0.0065%
Gebyr natten over, tid 22:00 (UTC)
Spænd 0.03

US100

12,566.80 Price
-0.450% 1D Chg, %
Long position, gebyr natten over -0.0183%
Short position, gebyr natten over 0.0071%
Gebyr natten over, tid 22:00 (UTC)
Spænd 3.0

XRP/USD

0.41 Price
-0.880% 1D Chg, %
Long position, gebyr natten over -0.0500%
Short position, gebyr natten over 0.0140%
Gebyr natten over, tid 22:00 (UTC)
Spænd 0.00327

Natural Gas

2.41 Price
-2.390% 1D Chg, %
Long position, gebyr natten over -0.1138%
Short position, gebyr natten over 0.0796%
Gebyr natten over, tid 22:00 (UTC)
Spænd 0.005

Leder du stadig efter en mægler, du kan stole på?

Deltag sammen med 485.000+ handlende over hele verden, der valgte at handle hos Capital.com

1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel